<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Eur J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur. J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>European Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1018-4813</issn>
<issn pub-type="epub">1476-5438</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27848942</article-id>
<article-id pub-id-type="pmc">5159770</article-id>
<article-id pub-id-type="pii">ejhg2016135</article-id>
<article-id pub-id-type="doi">10.1038/ejhg.2016.135</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Communicating microarray results of uncertain clinical significance in consultation summary letters and implications for practice</article-title>
<alt-title alt-title-type="running">Communicating microarray results of uncertain clinical significance</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Paul</surname>
<given-names>Jean Lillian</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0891-7035</contrib-id>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pope-Couston</surname>
<given-names>Rachel</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wake</surname>
<given-names>Samantha</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Burgess</surname>
<given-names>Trent</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tan</surname>
<given-names>Tiong Yang</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff5">5</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
</contrib>
<aff id="aff1"><label>1</label><institution>Murdoch Childrens Research Institute</institution>, Melbourne, VIC, <country>Australia</country></aff>
<aff id="aff2"><label>2</label><institution>Department of Paediatrics, The University of Melbourne</institution>, Melbourne, VIC, <country>Australia</country></aff>
<aff id="aff3"><label>3</label><institution>School of Languages &amp; Linguistics, The University of Melbourne</institution>, Melbourne, VIC, <country>Australia</country></aff>
<aff id="aff4"><label>4</label><institution>Genetic Health Service NZ (Northern Hub)</institution>, Auckland, <country>New Zealand</country></aff>
<aff id="aff5"><label>5</label><institution>Victorian Clinical Genetic Services</institution>, Melbourne, VIC, <country>Australia</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>Victorian Clinical Genetics Services</institution>, 4th Floor Royal Children's Hospital, Flemington Rd, Parkville, Melbourne, VIC 3052, <country>Australia</country>. Tel: +61399366576; Fax: +61383416390; E-mail: <email>tiong.tan@vcgs.org.au</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>01</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>16</day>
<month>11</month>
<year>2016</year>
</pub-date>
<volume>25</volume>
<issue>1</issue>
<fpage>22</fpage>
<lpage>30</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>05</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>31</day>
<month>08</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>09</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Macmillan Publishers Limited, part of Springer Nature.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Macmillan Publishers Limited, part of Springer Nature.</copyright-holder>
</permissions>
<abstract>
<p>Letter-writing is an integral practice for genetic health professionals. In Victoria, Australia, patients with a chromosomal variant of uncertain clinical significance (VUS) referred to a clinical geneticist (CG) for evaluation receive consultation summary letters. While communication of uncertainty has been explored in research to some extent, little has focused on how uncertainty is communicated within consultation letters. We aimed to develop a multi-layered understanding of the ways in which CGs communicate diagnostic uncertainty in consultation summary letters. We used theme-oriented discourse analysis of 49 consultation summary letters and thematic analysis of a focus group involving eight CGs. Results showed that CGs have become more confident in their description of VUS as ‘contributing factors' to patients' clinical features, but remain hesitant to assign definitive causality. CGs displayed strong epistemic stance when discussing future technological improvements to provide hope and minimise potentially disappointing outcomes for patients and families. CGs reported feeling overwhelmed by their workload associated with increasing numbers of patients with VUS, and this has led to a reduction in the number of review appointments offered over time. This study provides a rich description of the content and process of summary letters discussing VUS. Our findings have implications for letter-writing and workforce management. Furthermore, these findings may be of relevance to VUS identified by genomic sequencing in clinical practice.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>